FDA Approved: PIOGLITAZONE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for Pioglitazone (generic) under ANDA. Pioglitazone is used to treat type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

SUPPL AP for PIOGLITAZONE (PIOGLITAZONE)